Literature DB >> 17761406

Antidepressant drugs and memory: insights from animal studies.

Santiago Monleón1, Concepción Vinader-Caerols, M Carmen Arenas, Andrés Parra.   

Abstract

This is a selective review of the literature concerning the effects of antidepressant drugs on animal memory, which was performed with the aid of the PubMed database. Monoamine oxidase inhibitors tend to either have no effect on memory or result in its improvement. Studies with cyclic antidepressants have reported no effect or, more often, memory impairments. Pre-training administration of selective serotonin reuptake inhibitors (SSRIs) has been shown to have either no effect on memory or undermine it (with some isolated exceptions, in which improvements have been recorded), while post-training administration of SSRIs has been demonstrated to improve memory or have no effect. A small group formed by the remaining antidepressants has been shown to improve memory, with the exception of trazodone, which impairs memory. These findings are discussed in the light of knowledge regarding the actions of antidepressants on several neurotransmission systems. The possibility that the effects of antidepressants on memory are the core of the therapeutic effects of these drugs is also considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17761406     DOI: 10.1016/j.euroneuro.2007.07.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  8 in total

1.  The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.

Authors:  Liliana P Montezinho; Silke Miller; Niels Plath; Nanna Hovelsø Jensen; Jens-Jakob Karlsson; Louise Witten; Arne Mørk
Journal:  Psychopharmacology (Berl)       Date:  2010-07-30       Impact factor: 4.530

Review 2.  Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.

Authors:  Olivia O'Leary; Yvonne Nolan
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

3.  Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome.

Authors:  Valentina Mancini; Johanna Maeder; Karin Bortolin; Maude Schneider; Marie Schaer; Stephan Eliez
Journal:  Transl Psychiatry       Date:  2021-05-29       Impact factor: 6.222

4.  Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

Authors:  Laura Lyons; Maha ElBeltagy; Jariya Umka; Rachel Markwick; Carla Startin; Geoffrey Bennett; Peter Wigmore
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

5.  Memory Impairment following Acute Tricyclic Antidepressants Overdose.

Authors:  Nastaran Eizadi-Mood; Shahla Akouchekian; Ahmad Yaraghi; Mehrnazsadat Hakamian; Rasool Soltani; Ali Mohammad Sabzghabaee
Journal:  Depress Res Treat       Date:  2015-01-14

6.  A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase.

Authors:  Nobuo Tsuruoka; Yoshinori Beppu; Hirofumi Koda; Nobutaka Doe; Hiroshi Watanabe; Keiichi Abe
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

7.  Common mechanisms of pain and depression: are antidepressants also analgesics?

Authors:  Tereza Nekovarova; Anna Yamamotova; Karel Vales; Ales Stuchlik; Jitka Fricova; Richard Rokyta
Journal:  Front Behav Neurosci       Date:  2014-03-25       Impact factor: 3.558

8.  5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia.

Authors:  Alfredo Meneses
Journal:  Front Behav Neurosci       Date:  2014-06-12       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.